CSTL · Castle Biosciences Inc · Executive Compensation

$33.08 -0.11 (-0.33%) At close · Oct 23

Russell 2000 member Rebalance outlook locked

Market Cap

$1.01B

30.55M

Volume · Oct 23 203.08K Avg daily vol (3M) 399.95K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	President and CEO	$715,572	—	$5,283,595	—	$921,657	$20,250	$6,941,074
Tobin W. Juvenal	Chief Commercial Officer	$506,415	$13,926	$1,563,738	—	$342,701	$20,150	$2,446,931
Kristen M. Oelschlager	Chief Operating Officer	$506,415	$13,926	$1,563,738	—	$342,701	$20,150	$2,446,931

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	President and CEO	$686,400	—	—	—	$893,350	$26,234	$1,605,984
Frank Stokes	Chief Financial Officer	$488,800	$4,888	—	—	$316,742	$69,820	$880,250
Tobin W. Juvenal	Chief Commercial Officer	$482,300	$14,469	—	—	$312,530	$19,800	$829,099
Kristen M. Oelschlager	Chief Operating Officer	$482,300	$9,646	—	—	$312,530	$24,008	$828,484

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	President and CEO	$660,000	—	$6,102,902	—	$771,375	$18,300	$7,552,577
Tobin W. Juvenal	Chief Commercial Officer	$455,000	$13,650	$1,919,356	—	$295,750	$18,300	$2,702,056
Kristen M. Oelschlager	Chief Operating Officer	$455,000	$13,650	$1,919,356	—	$295,750	$18,300	$2,702,056
Frank Stokes	Chief Financial Officer	$470,000	$4,700	$1,757,713	—	$305,500	$69,160	$2,607,073

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	President and CEO	$625,000	—	$2,500,003	$2,656,954	$722,500	$17,400	$6,521,857
Frank Stokes	Chief Financial Officer	$450,000	$4,500	$999,993	$1,062,350	$289,800	$58,708	$2,865,351
Tobin W. Juvenal	Chief Commercial Officer	$425,000	$8,500	$999,993	$1,062,350	$273,700	$17,400	$2,786,943
Kristen M. Oelschlager	Chief Operating Officer	$425,000	$8,500	$999,993	$1,062,350	$273,700	$17,400	$2,786,943

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	President and CEO	$550,000	—	$1,268,982	$3,056,657	$457,600	$11,400	$5,344,639
Frank Stokes	Chief Financial Officer	$400,000	$4,000	$473,280	$1,087,530	$208,000	$44,257	$2,217,067
Bernhard E. Spiess	Chief Business Officer	$350,000	$3,150	$354,960	$806,861	$163,800	$11,400	$1,335,211

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	President and Chief Executive Officer	$769,562	$18,690	—	$2,991,141	$341,760	$11,200	$4,132,353
Frank Stokes	Chief Financial Officer	$327,117	$7,748	—	$968,897	$141,680	$52,790	$1,498,232
Federico A. Monzon	Chief Medical Officer	$326,781	$8,101	—	$644,397	$148,133	$11,200	$1,138,612

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	President and Chief Executive Officer	$409,500	—	—	$161,040	$206,000	$14,218	$790,758
Frank Stokes	Chief Financial Officer	$275,000	—	—	$177,347	$96,250	$44,732	$593,329
Federico A. Monzon	Chief Medical Officer	$317,075	—	—	$33,387	$112,400	$11,000	$473,862

Executive changes

Person	Role	Change	Effective	Filed
Rodney Cotton	Class II director	Appointed	2024-03-26	2024-03-27

Leadership

Derek Maetzold CEO, Board Member
Frank Stokes CFO
Kristen M. Oelschlager COO
Kimberlee Caple Board Member
Miles Harrison Board Member
Rodney Cotton Board Member

Key facts CIK 1447362 CUSIP 14843C105 13F (30d) 24 filings 24 filers Visit website Investor relations